Michael B. Jebsen
2015
In 2015, Michael B. Jebsen earned a total compensation of $425K as President, Chief Financial Officer at Tenax Therapeutics, a 92% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $128,250 |
|---|---|
| Salary | $285,000 |
| Stock Awards | $2,141 |
| Other | $9,600 |
| Total | $424,991 |
Jebsen received $285K in salary, accounting for 67% of the total pay in 2015.
Jebsen also received $128.3K in non-equity incentive plan, $2.1K in stock awards and $9.6K in other compensation.
Rankings
In 2015, Michael B. Jebsen's compensation ranked 11,392nd out of 13,638 executives tracked by ExecPay. In other words, Jebsen earned more than 16.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,392 out of 13,638 | 17th |
Division Manufacturing | 4,360 out of 5,187 | 16th |
Major group Chemicals And Allied Products | 1,606 out of 1,857 | 14th |
Industry group Drugs | 1,326 out of 1,531 | 13th |
Industry Pharmaceutical Preparations | 1,025 out of 1,179 | 13th |
Source: SEC filing on August 17, 2015.
Jebsen's colleagues
We found one more compensation record of an executive who worked with Michael B. Jebsen at Tenax Therapeutics in 2015.
2015
John Kelley
Tenax Therapeutics